Bespoke, project
specific biomarker assays

Pharmacodynamic models can be created for high throughput in vivo screening with hard endpoints across all therapeutic areas.

  • Allows efficacy, potency and duration assessment
  • Translational to disease model testing, preclinical and clinical development
  • We can assess biomarkers in vitro (rodents or clinical samples), in vivo or ex vivo
Example Protocols >